Class 4 Medicines Defect Information: Rosemont Pharmaceuticals Limited, Mycophenolate Mofetil 1g/5ml Oral Suspension, EL(24)A/59
Rosemont Pharmaceuticals Limited has informed the MHRA that the Press-In-Bottle-Adaptor (PIBA) supplied with the batches listed above may cause the medicine to leak when attempting to withdraw a dose.
DMRC reference number
DMRC-33616486
Company name
Rosemont Pharmaceuticals Limited
Mycophenolate Mofetil 1g / 5ml Oral Suspension, PLGB 00427/0272
SNOMED Code
42314611000001100
| Batch No | Expiry Date | Pack Size | First Distributed |
|---|---|---|---|
| MYC23001 | May 2025 | 175ml | May 2024 |
| MYC24001 | Jun 2025 | 175ml | May 2024 |
| MYC24002 | Jun 2025 | 175ml | May 2024 |
| MYC24003 | Jun 2025 | 175ml | Jun 2024 |
| MYC24004 | Jun 2025 | 175ml | Jun 2024 |
| MYC24005 | Jul 2025 | 175ml | Jun 2024 |
| MYC24006 | Jul 2025 | 175ml | Jun 2024 |
| MYC24007 | Aug 2025 | 175ml | Sep 2024 |
| MYC24008 | Dec 2025 | 175ml | Not yet distributed |
Active Pharmaceutical Ingredient: mycophenolate mofetil
Brief description of the problem
Rosemont Pharmaceuticals Limited has informed the MHRA that the Press-In-Bottle-Adaptor (PIBA) supplied with the batches listed above may cause the medicine to leak when attempting to withdraw a dose. Further to this, in rare instances, the seal on the PIBA can get damaged and small pieces of plastic may break off.
Advice for healthcare professional
Healthcare professionals should continue to prescribe the product, the batches listed are not being recalled. The PIBA is an aid to dispensing and the product can be administered accurately using the syringe without the PIBA.
Specific ‘Advice for patients’ is included in this alert for the safe and accurate administering the product. Please provide these instructions to patients when dispensing the product.
The specific instructions in the Patient Information Leaflet (PIL) for cleaning the syringe between administration of doses should continue unchanged.
Advice for patients
If you have received one of the affected batches in the table, it is important to continue to take your medicine as prescribed by your healthcare professional. Stopping this medication suddenly can make you ill. This product is not being recalled and the following instructions below allow for the continued safe use of the product
The PIBA is the small plastic part included in the package with your medication. It is designed to fit tightly in the neck of the bottle to reduce mess when drawing up doses.
Bottles already in use
If you have already opened a bottle of the product, leave the PIBA in the bottle and continue to use as directed in the Patient Information Leaflet (PIL) that comes with your medicine. Removing the PIBA will increase the risk of damaging the plastic.
New bottles not yet opened
The PIBA helps with drawing up the correct dose of medicine but it not necessary to get an accurate dose. The product can be drawn up accurately using the syringe without the PIBA. Please follow the instructions below to get the right amount directly from the medicine bottle:
- Discard the PIBA provided.
- Shake the bottle well, immediately prior to use.
- Remove the cap by pressing it down and turning anticlockwise.
- Keeping the bottle standing upright, insert the syringe supplied into the bottle ensuring the tip of the syringe goes below the level of the liquid.
- Fill the syringe with a small amount of medicine by pulling the piston up whilst maintaining the tip of the syringe below the level of the liquid, then push the piston down to remove any possible bubbles whilst keeping some medicine in the syringe.
- Pull the piston upward to the graduation mark corresponding to the quantity in millilitres (ml) prescribed by your doctor.
- Remove the syringe from the bottle.
- Close the bottle with the plastic screw cap.
- Empty the contents of the syringe directly into your mouth. Do not mix the medicine with any other liquid when you swallow it.
- Immediately after use, wash the syringe as per the instructions in the PIL, using water only and leaving it to dry in the air.
If you have any concerns about the medicine you are using, please contact your healthcare professional.
Patients who experience adverse reactions or have any questions about the medication, should seek medical attention. Any suspected adverse reactions should also be reported via the MHRA Yellow Card scheme.
Further Information
For medical information enquiries please contact pharmacovigilance@rosemontpharma.com, or telephone 0113 244 1400.
For stock control enquiries please contact customerservices@rosemontpharma.com, or telephone 0113 244 1999.
Recipients of this Medicines Recall should bring it to the attention of relevant contacts by copy of this notice. NHS regional teams are asked to forward this to community pharmacists and dispensing general practitioners for information.
Yours faithfully
Defective Medicines Report Centre
10 South Colonnade
Canary Wharf
London
E14 4PU
Telephone +44 (0)20 3080 6574
Download document